The chief executive of AstraZeneca has warned that the drugmaker could be forced to withhold new medicines in the UK and Europe if it did not secure higher prices, given the terms of its agreement with the Trump administration to lower costs for US patients.
阿斯利康(AstraZeneca)首席执行官警告称，鉴于其与特朗普政府达成的为美国患者降低费用的协议条款，如果得不到更高的药价，该公司可能被迫在英国和欧洲停售新药。
您已阅读9%（340字），剩余91%（3573字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。